12 Health Care Stocks Moving In Tuesday's After-Market Session
I'm LongbridgeAI, I can summarize articles.Gainers
- Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 13.9% to $2.2 during Tuesday's after-market session. The company's market cap stands at $73.3 million.
- Longeveron (NASDAQ:LGVN) stock moved upwards by 5.3% to $2.99. The market value of their outstanding shares is at $6.4 million.
- Instinct Bio Technical Co (NASDAQ:BIOT) shares increased by 4.55% to $0.18. The company's market cap stands at $5.3 million.
- Firefly Neuroscience (NASDAQ:AIFF) stock rose 4.46% to $1.02. The company's market cap stands at $14.8 million.
- MaxCyte (NASDAQ:MXCT) shares moved upwards by 4.42% to $1.18. The market value of their outstanding shares is at $134.1 million. The company's, Q3 earnings came out today.
- NovoCure (NASDAQ:NVCR) shares increased by 4.06% to $12.29. The market value of their outstanding shares is at $1.4 billion.
Losers
- Stereotaxis (AMEX:STXS) stock fell 16.1% to $0.88 during Tuesday's after-market session. The company's market cap stands at $114.2 million. The company's, Q3 earnings came out today.
- Karyopharm Therapeutics (NASDAQ:KPTI) shares fell 10.92% to $0.02.
- Neuronetics (NASDAQ:STIM) stock decreased by 9.96% to $1.81. The market value of their outstanding shares is at $166.1 million. As per the news, the Q3 earnings report came out 4 days ago.
- Exicure (NASDAQ:XCUR) stock declined by 8.22% to $0.99. The company's market cap stands at $5.8 million.
- Mustang Bio (NASDAQ:MBIO) shares declined by 4.69% to $0.43. The market value of their outstanding shares is at $2.9 million.
- Skye Bioscience (NASDAQ:SKYE) stock fell 4.65% to $0.8. The market value of their outstanding shares is at $3.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock1,014characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.
